Ovid Therapeutics Inc.
Ovid Therapeutics Inc. (OVID) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OVID · as of Jun 9, 2026
Key Statistics
Explore Ovid Therapeutics Inc. Data
ovid stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 78.6%
The OVID analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $5.50, representing +133.05% upside from the current price of $2.36.
Competitors & Peers
ovid competitorsOVID
CLNN
CNTB
CNTX
IFRX
IMAStock Performance
Full HistoryAbout Ovid Therapeutics Inc.
Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's …
what is ovid therapeutics inc. · ovid stock overview · ovid therapeutics inc. company profile · who is ovid therapeutics inc. ceo · ovid NASDAQ · ovid therapeutics inc. headquarters · ovid therapeutics inc. business segments
About Stock Overview & Key Data
Ovid Therapeutics Inc. (OVID) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 5, 2017. As of the latest trading session, OVID stock price is $2.36, with a market capitalization of $311.2M. The stock has returned +612.56% over the past 12 months and +44.79% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Ovid Therapeutics Inc. stock is Buy, with an average 12-month price target of $5.50. In fiscal year 2025, Ovid Therapeutics Inc. reported revenue of $7.3M and net income of -$17.4M. For detailed data — including Ovid Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ovid Therapeutics Inc. (OVID) stock price is $2.36. The stock is traded on NASDAQ under the ticker symbol OVID. The 52-week range is $0.27 – $3.10.